CD47 and leukemia: Additionally, studies using lentiviral vectors to deliver CD47‐siRNA into AML‐derived LSCs demonstrated effective inhibition of LSC proliferation and promotion of apoptosis, highlighting CD47 as a valuable target for leukemia treatment and prognostic prediction.195